Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]

Katsuyuki Hotta; Akira Inoue; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto; Toshihiro Nukiwa

doi:10.1016/j.lungcan.2005.07.006

Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]

Katsuyuki Hotta, Akira Inoue, Katsuyuki Kiura, Hiroshi Ueoka, Mitsune Tanimoto, Toshihiro Nukiwa

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	413-415
Number of pages	3
Journal	Lung Cancer
Volume	50
Issue number	3
DOIs	https://doi.org/10.1016/j.lungcan.2005.07.006
Publication status	Published - Dec 1 2005

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Access to Document

10.1016/j.lungcan.2005.07.006

Cite this

Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer : Results from a prospective feasibility study [1]. / Hotta, Katsuyuki; Inoue, Akira; Kiura, Katsuyuki; Ueoka, Hiroshi; Tanimoto, Mitsune; Nukiwa, Toshihiro.

In: Lung Cancer, Vol. 50, No. 3, 01.12.2005, p. 413-415.

Research output: Contribution to journal › Letter › peer-review

@article{f1639d7b859e49899a1e7baaccc08c3a,

title = "Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]",

author = "Katsuyuki Hotta and Akira Inoue and Katsuyuki Kiura and Hiroshi Ueoka and Mitsune Tanimoto and Toshihiro Nukiwa",

year = "2005",

month = dec,

day = "1",

doi = "10.1016/j.lungcan.2005.07.006",

language = "English",

volume = "50",

pages = "413--415",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer

T2 - Results from a prospective feasibility study [1]

AU - Hotta, Katsuyuki

AU - Inoue, Akira

AU - Kiura, Katsuyuki

AU - Ueoka, Hiroshi

AU - Tanimoto, Mitsune

AU - Nukiwa, Toshihiro

PY - 2005/12/1

Y1 - 2005/12/1

UR - http://www.scopus.com/inward/record.url?scp=33644550293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644550293&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2005.07.006

DO - 10.1016/j.lungcan.2005.07.006

M3 - Letter

C2 - 16154232

AN - SCOPUS:33644550293

VL - 50

SP - 413

EP - 415

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 3

ER -

Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this